MS SB2388 | 2025 | Regular Session
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Engrossed on February 5 2025 - 50% progression
Action: 2025-02-11 - Referred To Medicaid;Insurance
Pending: House Medicaid Committee
Text: Latest bill text (Engrossed) [HTML]
Status: Engrossed on February 5 2025 - 50% progression
Action: 2025-02-11 - Referred To Medicaid;Insurance
Pending: House Medicaid Committee
Text: Latest bill text (Engrossed) [HTML]
Summary
An Act To Provide That The Division Of Medicaid, In Establishing And Maintaining The Preferred Drug List, Shall Ensure That No Nonopioid Drug Approved By The United States Food And Drug Administration For The Treatment Or Management Of Pain Shall Be Disadvantaged Or Discouraged With Respect To Coverage Relative To Any Opioid Or Narcotic Drug For The Treatment Or Management Of Pain On Such Preferred Drug List; To Provide That The Division, In Establishing And Maintaining The Preferred Drug List, Shall Ensure That No Nonstatin Medication That Has A Unique Indication To Reduce The Risk Of A Major Cardiovascular Event In Primary And Secondary Prevention Patients Shall Be Disadvantaged Or Discouraged With Respect To Coverage Relating To Any Drug For The Treatment Or Management Of Cardiovascular Events On Such Preferred Drug List; And For Related Purposes.
Title
Medicaid; create provisions effecting parity in the prescription of pain medication.
Sponsors
Roll Calls
2025-02-05 - Senate - Senate Passed As Amended (Y: 51 N: 0 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2025-02-11 | House | Referred To Medicaid;Insurance |
| 2025-02-07 | Senate | Transmitted To House |
| 2025-02-05 | Senate | Passed As Amended |
| 2025-02-05 | Senate | Amended |
| 2025-02-05 | Senate | Committee Substitute Adopted |
| 2025-01-30 | Senate | Title Suff Do Pass Comm Sub |
| 2025-01-29 | Senate | DR - TSDPCS: ME To IN |
| 2025-01-20 | Senate | Referred To Medicaid;Insurance |
